Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,016 across all filing types
Latest filing 2026-03-24 Transaction in Own Shar…
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 95% confidence The document is an RNS announcement titled “Transaction in own shares” by GSK plc, detailing the number of shares purchased, prices, dates, venues, and treasury holdings as part of a buyback program. It provides a full schedule of repurchase transactions. This fits the “Transaction in Own Shares” category rather than a general regulatory filing or capital update. Hence it should be classified under POS.
2026-03-24 English
6-K - GSK plc (0001131399) (Filer)
Regulatory Filings
2026-03-23 English
Director/PDMR Shareholding
Director's Dealing Classification · 95% confidence The document is an RNS disclosure titled “Transaction notification” detailing multiple purchases of GSK plc ordinary shares and ADS by PDMRs and persons closely associated with them (including names, positions, trade dates, volumes, prices, and venues). This matches insider trading disclosures by directors. According to the filing definitions, this falls under Director’s Dealing (Code: DIRS).
2026-03-23 English
6-K - GSK plc (0001131399) (Filer)
Regulatory Filings
2026-03-23 English
Admission to Trading
Share Issue/Capital Change Classification · 85% confidence The document is an RNS notice from GSK plc titled “Admission to trading” detailing the admission of 96,525 further ordinary shares (ISIN GB00BN7SWP63) under an existing block listing relating to the Share Save Plan. It is not an earnings report, management change, or proxy solicitation; instead it announces a change in capital (new shares being admitted to trading). Therefore, this fits the definition of Share Issue/Capital Change (SHA).
2026-03-23 English
6-K - GSK plc (0001131399) (Filer)
Regulatory Filings
2026-03-23 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.